X4 Pharmaceuticals, Inc. ( XFOR) - Key Metrics
XFOR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.02 | -$0.22 | -$0.14 | -$0.14 |
| 2025Q3 | $0.04 | -$0.69 | -$0.64 | -$0.64 |
| 2025Q2 | $0.27 | -$3.47 | -$4.03 | -$4.03 |
| 2025Q1 | $4.21 | $0.04 | -$1.81 | -$1.81 |
XFOR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.62 |
| 2025Q3 | ? | -1.24 |
| 2025Q2 | ? | -0.14 |
| 2025Q1 | ? | 42.99 |
XFOR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -3.51% | ? |
| 2025Q3 | -18.80% | ? |
| 2025Q2 | -212.29% | ? |
| 2025Q1 | -25.50% | ? |
XFOR
Price: $4.04
52 week price:
Earnings Per Share: -2.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 471700
Market Capitalization: 361.2 million